Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial.

MLA

Feldman, Arthur M., et al. “Cost Effectiveness of Cardiac Resynchronization Therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial.” Journal of the American College of Cardiology, vol. 46, no. 12, Dec. 2005, pp. 2311–21. EBSCOhost, https://doi.org/10.1016/j.jacc.2005.08.033.

APA

Feldman, A. M., de Lissovoy, G., Bristow, M. R., Saxon, L. A., De Marco, T., Kass, D. A., Boehmer, J., Singh, S., Whellan, D. J., Carson, P., Boscoe, A., Baker, T. M., & Gunderman, M. R. (2005). Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial. Journal of the American College of Cardiology, 46(12), 2311–2321. https://doi.org/10.1016/j.jacc.2005.08.033

Chicago

Feldman, Arthur M, Gregory de Lissovoy, Michael R Bristow, Leslie A Saxon, Teresa De Marco, David A Kass, John Boehmer, et al. 2005. “Cost Effectiveness of Cardiac Resynchronization Therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial.” Journal of the American College of Cardiology 46 (12): 2311–21. doi:10.1016/j.jacc.2005.08.033.